Select Language

English

Down Icon

Select Country

Germany

Down Icon

Migraine plus depression: Fremanezumab appears to have a double effect

Migraine plus depression: Fremanezumab appears to have a double effect
Results of the UNITE study Migraine plus depression: Fremanezumab appears to have a double effect

Migraine and major depression often co-occur. The monoclonal CGRP antibody fremanezumab has been shown in a study to be able to alleviate both comorbidities simultaneously.

Arzte zeitung

Arzte zeitung

Similar News

All News
Animated ArrowAnimated ArrowAnimated Arrow